home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Multi-Tasking Sensor Of Immune 'Danger'

 
  March, 6 2008 10:25
your information resource in human molecular genetics
 
     

Data explaining how a single sensor of 'danger' manages to activate two distinct host immune defense signaling pathways is presented in a paper published online in Nature Immunology. TLR4, a detector of a bacterial component, triggers activation of a signaling pathway culminating in production of type I interferon -- a protein that elicits a state of immune system 'alert' -- and of a signaling cascade eliciting other pro-inflammatory signaling molecules. Unlike other type I interferon-inducing receptors, which reside inside immune cells, TLR4 sits on the surface of immune cells.

Ruslan Medzhitov and colleagues show that TRAM, a protein that binds the intracellular tail of TLR4, routes TLR4 from the cell surface to intracellular compartments. This TRAM-mediated trafficking allows TLR4 to 'multi-task' by sequentially activating two signaling pathways -- first one from the cell surface and then a second from within the cell interior.

Author contact:

Ruslan Medzhitov (Yale University School of Medicine, New Haven, Connecticut, USA)
E-mail: ruslan.medzhitov@yale.edu

Abstract available online.

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.